More evidence for dolutegravir as first-line ART for all
ContributorsEstill, Janne Anton Markus; Bertisch, Barbara
Published inThe Lancet HIV, vol. 7, no. 3, p. e154-e155
Publication date2020
Keywords
- Africa South of the Sahara
- Alkynes
- Benzoxazines
- Cyclopropanes
- HIV Infections
- Heterocyclic Compounds, 3-Ring
- Humans
- Oxazines
- Piperazines
- Pyridones
- Risk Assessment
Research group
Funding
- Swiss National Science Foundation - 163878
Citation (ISO format)
ESTILL, Janne Anton Markus, BERTISCH, Barbara. More evidence for dolutegravir as first-line ART for all. In: The Lancet HIV, 2020, vol. 7, n° 3, p. e154–e155. doi: 10.1016/S2352-3018(19)30414-X
Main files (2)
Article (Accepted version)
Article (Published version)
Identifiers
- PID : unige:153650
- DOI : 10.1016/S2352-3018(19)30414-X
- PMID : 32035042
ISSN of the journal2352-3018
